Search

Your search keyword '"Peters, Anne"' showing total 35 results
Start Over Author "Peters, Anne" Journal diabetes
35 results on '"Peters, Anne"'

1. 259-OR: Stem Cell–Derived, Fully Differentiated Islet Cells for Type 1 Diabetes

Author

MARKMANN, JAMES F., primary, NAJI, ALI, additional, RICKELS, MICHAEL R., additional, ALBA, MARIA, additional, MARIGOWDA, GAUTHAM, additional, ROSS, LEORAH, additional, WANG, CHENKUN, additional, PAGLIUCA, FELICIA, additional, SANNA, BASTIANO, additional, KEAN, LESLIE S., additional, PETERS, ANNE L., additional, WITKOWSKI, PIOTR, additional, and RICORDI, CAMILLO, additional

Published
2022
Full Text
View/download PDF

3. 279-OR: Self-Efficacy, Diabetes Distress, Self-Care, and Blood Glucose: Within-Person Pathways in Adults with T1D

Author

GONZALEZ, JEFFREY S., primary, SPRUIJT-METZ, DONNA, additional, SCHNEIDER, STEFAN, additional, PETERS, ANNE L., additional, CRANDALL, JILL P., additional, CRESPO-RAMOS, GLADYS, additional, MENDEZ-RODRIGUEZ, HEIDY, additional, HOOGENDOORN, CLAIRE J., additional, AGARWAL, SHIVANI, additional, JIN, HAOMIAO, additional, PHAM, LOREE T., additional, ALI, AINA, additional, LEE, PEY-JIUAN, additional, RUELAS, VALERIE F., additional, BASILE, ROSE, additional, and PYATAK, ELIZABETH, additional

Published
2022
Full Text
View/download PDF

6. 278-OR: ADA Presidents' Select Abstract: Impact of Overnight Blood Glucose on Next-Day Functioning in T1D

Author

PYATAK, ELIZABETH, primary, SPRUIJT-METZ, DONNA, additional, SCHNEIDER, STEFAN, additional, CRANDALL, JILL P., additional, PETERS, ANNE L., additional, JIN, HAOMIAO, additional, AGARWAL, SHIVANI, additional, PHAM, LOREE T., additional, ALI, AINA, additional, HOOGENDOORN, CLAIRE J., additional, CRESPO-RAMOS, GLADYS, additional, MENDEZ-RODRIGUEZ, HEIDY, additional, LEE, PEY-JIUAN, additional, RUELAS, VALERIE F., additional, BASILE, ROSE, additional, and GONZALEZ, JEFFREY S., additional

Published
2022
Full Text
View/download PDF

7. 346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon

Author

BATTELINO, TADEJ, primary, BAILEY, TIMOTHY S., additional, TEHRANCHI, RAMIN, additional, KLAFF, LESLIE J., additional, PIEBER, THOMAS, additional, HÖVELMANN, ULRIKE, additional, PLUM-MOERSCHEL, LEONA, additional, MELGAARD, ANITA E., additional, ARONSON, RONNIE, additional, DIMEGLIO, LINDA, additional, DANNE, THOMAS, additional, and PETERS, ANNE L., additional

Published
2021
Full Text
View/download PDF

8. 1629-P: Association of Patient-Reported Outcomes (PROs) Scores with Glycemic Target Achievement in Type 1 Diabetes (T1D) in the SAGE Study

Author

WILMOT, EMMA G., primary, BLASCO, FRANCISCO JAVIER AMPUDIA, additional, BERARD, LORI, additional, BRETTE, SANDRINE, additional, CALLIARI, LUIS EDUARDO P., additional, FITTS, EMILY, additional, CLOSE, KELLY L., additional, GAGLIARDINO, JUAN J., additional, LAUAND, FELIPE, additional, PETERS, ANNE L., additional, RENARD, ERIC, additional, DE CLIMENS, AUDE ROBOREL, additional, and SEUFERT, JOCHEN, additional

Published
2020
Full Text
View/download PDF

10. 1626-P: Differences in Patient-Reported Outcomes (PROs) by Age and Region in Adults with Type 1 Diabetes (T1D) in the SAGE Study

Author

BERARD, LORI, primary, BLASCO, FRANCISCO JAVIER AMPUDIA, additional, BRETTE, SANDRINE, additional, BRUTTOMESSO, DANIELA, additional, CLOSE, KELLY L., additional, IKEGAMI, HIROSHI, additional, JURIŠIC-ERŽEN, DUBRAVKA, additional, LAUAND, FELIPE, additional, PETERS, ANNE L., additional, PILORGET, VALERIE, additional, BALAMURUGAN, RAMANATHAN, additional, RENARD, ERIC, additional, WILMOT, EMMA G., additional, and DE CLIMENS, AUDE ROBOREL, additional

Published
2020
Full Text
View/download PDF

26. Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (The European inTandem2 Study)

Author

DANNE, THOMAS, primary, CARIOU, BERTRAND, additional, BANKS, PHILLIP L., additional, BRANDLE, MICHAEL, additional, BRATH, HELMUT, additional, FRANEK, EDWARD, additional, KUSHNER, JAKE A., additional, LAPUERTA, PABLO, additional, MCGUIRE, DARREN K., additional, PETERS, ANNE L., additional, SAWHNEY, SANGEETA, additional, and STRUMPH, PAUL, additional

Published
2018
Full Text
View/download PDF

27. Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2)

Author

DANNE, THOMAS, primary, CARIOU, BERTRAND, additional, BUSE, JOHN B., additional, GARG, SATISH K., additional, ROSENSTOCK, JULIO, additional, BANKS, PHILLIP L., additional, KUSHNER, JAKE A., additional, MCGUIRE, DARREN K., additional, PETERS, ANNE L., additional, SAWHNEY, SANGEETA, additional, and STRUMPH, PAUL, additional

Published
2018
Full Text
View/download PDF

28. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study—A Contemporary Prediabetes Cohort

Author

LEBLANC, ERIN, primary, PRATLEY, RICHARD E., additional, DAWSON-HUGHES, BESS, additional, STATEN, MYRLENE A., additional, SHEEHAN, PATRICIA R., additional, LEWIS, MICHAEL R., additional, PETERS, ANNE L., additional, KIM, SUN H., additional, CHATTERJEE, RANEE, additional, ARODA, VANITA, additional, CHADHA, CHHAVI, additional, and PITTAS, ANASTASSIOS, additional

Published
2018
Full Text
View/download PDF

29. Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1)

Author

BUSE, JOHN B., primary, GARG, SATISH K., additional, ROSENSTOCK, JULIO, additional, BAILEY, TIMOTHY S., additional, BANKS, PHILLIP L., additional, BODE, BRUCE W., additional, DANNE, THOMAS, additional, KUSHNER, JAKE A., additional, LANE, WENDY, additional, LAPUERTA, PABLO, additional, MCGUIRE, DARREN K., additional, PETERS, ANNE L., additional, REED, JOHN H., additional, SAWHNEY, SANGEETA, additional, and STRUMPH, PAUL, additional

Published
2018
Full Text
View/download PDF

30. Development of a Diabetes Registry in an IPA Setting--Outpatient and Inpatient Applications

Author

OSSORIO, R. CLIFFORD, PETERS, ANNE L., CHEN, LISA S., BAMFORD, STEPHANIE, DERACO, MARY R., and WALD, BARTON G.

Subjects
Diabetes -- Research, Health
Abstract

Collecting accurate data from clinically independent and geographically disparate medical and IPA groups, using varying medical record and information systems, has been difficult. However, tracking diabetes process and outcomes measures [...]

Published
1999

31. Improvements in Glycemic Control with a Care Manager-Based Diabetes Control Program

Author

PETERS, ANNE L., YOUNG, ROY T., KNIGHT, KEVIN K., and PORTER, MARTIN H.

Subjects
Diabetes -- Research, Health
Abstract

It is well known that non-physician diabetes Care managers can improve outcomes in diabetic patients. However, neither the optimal duration of patient follow-up nor the best approach to supervision by [...]

Published
1999

33. Revisiting the Oral Glucose Tolerance Test (OGTT) Criterion for the Diagnosis of Diabetes

Author

DAVIDSON, MAYER B, SCHRIGER, DAVID L, PETERS, ANNE L, and LORBER, BRETT

Subjects
Diabetes -- Research, Health
Abstract

Because the distribution of glucose concentrations in most populations is unimodal, there is no obvious cutpoint above which to diagnose diabetes. The diagnostic 2-hour glucose concentration on an OGTT of [...]

Published
1999

34. Adult and Childhood Obesity and Diabetes in Underserved Communities.

Author

Peters, Anne, Iverson, Ellen, Ruelas, Valerie, Kipke, Michele, and Kaufman, Francine

Subjects
*DIABETES, *OBESITY, *OVERWEIGHT children, *CHILDHOOD obesity, *MEDICALLY underserved areas
Abstract

Community-based interventions were developed for two low-income areas, East Los Angeles (ELA, Latino) and South Los Angeles (SLA, African American/Latino), using community advisory boards and resident interviews. 90% of residents in each community live under 185% of the federal poverty level. Pre-intervention data was collected via a 30-minute random digit dial phone survey to assess baseline variables related to diabetes and obesity. Data is reported on 502 adults and 269 children. In our survey, adult BMIs were consistent with national trends. However, the children were heavier with 13% at risk for overweight and 35% overweight in ELA. SLA children were even heavier at 24% and 40%, respectively. Most adults (71%) had a perception that their children were normal weight but calculated child BMIs were much higher. Over 63% of adults tried losing weight in the past 12 months with only 2 utilizing a program such as Weight Watchers or seeing a dietitian. Individuals less than 50 years of age had poorer eating habits than those 50 years of age or older (P<.001). ELA adults (12.7%) and SLA adults (16.3%) reported a diagnosis of diabetes, which is 3% higher than national trends. Those with diabetes had a higher mean BMI (33.2±9.2) compared to those without (28.2±6.1) and were more likely (P<.001) to have other health conditions (e.g. hypertension). Additionally, US born were more likely to have diabetes than those who lived in the US less than 10 years (P=.044). Individuals with diabetes exhibited healthier eating patterns than those without diabetes but did not exercise more (P<.001). Adults who had eaten fast food one or more times the day prior to being surveyed (35%) were more likely to be US born or lived in the US 10 or more years (P=.001) and were more concerned about their weight (P=.03) but had less healthy eating patterns (P<.001). 52% of ELA adults and 49% in SLA worried about running out of food in the past 12 months, and 38% of ELA and 46% of SLA residents actually ran out of food. In conclusion, diabetes in adults and obesity in children are issues confronting low-income areas in LA. These baseline data should allow for comparison as community based initiatives designed to prevent diabetes and obesity are implemented. [ABSTRACT FROM AUTHOR]

Published
2007

35. Continuous Versus Episodic Diabetes Disease Management in an Underserved Population.

Author

Wei-An (Andy) Lee, Beale, Elizabeth, and Peters, Anne

Subjects
DIABETES prevention, HEALTH promotion, PEOPLE with diabetes, MEDICALLY underserved areas
Abstract

In public healthcare systems uninsured patients with diabetes are increasingly common. In order to improve outcomes, the Department of Health Services in Los Angeles County initiated a pilot diabetes disease management program in East Los Angeles, in an area where 90% of adults live below 185% of the federal poverty level. To control costs in the diabetes program patients are graduated back to their PCP after 6 months or when the A1C is <8%, whichever comes first. Patients am asked to return yearly for an annual assessment. This prospective study was designed to follow patients enrolled in the program and randomized to continuous follow-up or discharge at 6 months. Eighty-one patients were randomized to continuous (CONT) and 82 to episodic (EPI) follow-up. All patients were Latino, the majority from Mexico. Spanish was the most most common primary language (81% in CONT/88% in EPI). Seven years was the average time spent in school, and ∼25% had no formal education. The average age was 55 yrs, and duration of diabetes 11 yrs. Half were on SA's, 75% were on metformin, 23% on pioglitazone and 33% on insulin (patients were on one or more agent). The initial A1C was 8.9(2.0)(mean)(stdev)and was not different between groups. At 6 months, when both groups were receiving the same care, there was no difference in A1C's [7.9(1.8)CONT vs 7.7(1.6)EPI]. At one and two years the A1C's were also not significantly different in the two groups. At 6 months 65%(CONT) and 71%(EPI) patients acheived an A1C of <8% (the target for referral back to primary care). Approximately 60% of patients in both groups had A1C levels <8% at 12 and 24 months. Many fewer reached an A1C of <7% (CONT = 32% at 6 mos, 28% at 12 mos and 16% at 24 mos; EPI = 30% at 6 mos, 38% at 12 mos and 26% at 24 mos, p = NS). Therefore, improvements in A1C levels are possible in an underserved Latino population. Patients did as well when seen episodically as when seen continuously in the program. When analyzed based on A1C level achieved, rather than treatment group, those who reached an A1C of <7% had fewer ER/walk-in visits than did those with higher A1C levels (p=0.0319). Thus, increasingly cost-effective models for diabetes care can be developed, maximally utilizing limited resources and reducing costly urgent care visits. [ABSTRACT FROM AUTHOR]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results